Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.2%

5 terminated/withdrawn out of 49 trials

Success Rate

84.8%

-1.8% vs industry average

Late-Stage Pipeline

31%

15 trials in Phase 3/4

Results Transparency

14%

4 of 28 completed trials have results

Key Signals

6 recruiting4 with results

Enrollment reporting

Analytics

N/A
17(47.2%)
Phase 4
12(33.3%)
Phase 3
3(8.3%)
Phase 2
2(5.6%)
Phase 1/2
1(2.8%)
Phase 2/3
1(2.8%)
36Total
N/A(17)
Phase 4(12)
Phase 3(3)
Phase 2(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials
NCT07683923Phase 4Not Yet Recruiting

Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial

Role: collaborator

NCT04848844Recruiting

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)

Role: collaborator

NCT05776212Recruiting

Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Role: collaborator

NCT05334888Recruiting

Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach

Role: collaborator

NCT04634266Not ApplicableActive Not Recruiting

TRICuspid Intervention in Heart Failure Trial

Role: collaborator

NCT03112980Not ApplicableActive Not Recruiting

Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality

Role: collaborator

NCT01165827Terminated

German Aortic Valve Registry

Role: collaborator

NCT04359238Not ApplicableCompleted

activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch

Role: collaborator

NCT04396899Phase 1/2Recruiting

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

Role: collaborator

NCT03463317Phase 4Completed

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

Role: collaborator

NCT05570409Phase 2/3Terminated

Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

Role: collaborator

NCT04727073Phase 3Terminated

Spironolactone in the Treatment of Heart Failure

Role: collaborator

NCT03609385Completed

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE

Role: collaborator

NCT02618577Phase 3Terminated

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Role: collaborator

NCT03036462Phase 4Completed

Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

Role: collaborator

NCT05826444Unknown

Microvascular Cardiac Allograft Vasculopathy Trial

Role: collaborator

NCT02675244Not ApplicableCompleted

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Role: collaborator

NCT04558723Not ApplicableRecruiting

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy

Role: collaborator

NCT02051712Phase 3Unknown

Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure

Role: collaborator

NCT04527731Completed

Physical Activity Level During Pregnancy

Role: collaborator